Clinical Trials Browser

INDUSTRY × emibetuzumab × Gastrointestinal × Clear all

NCT02082210 2020-12-19

A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer

Phase 1/2 Completed

97 enrolled 20 charts

GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Liver Neoplasms

NCT01874938 2015-01-16

A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms